Clinical Trial Update: A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT [Phase 1, Phase 2]

View source ↗

Summary

Genenta Science is conducting a Phase 1/2 study of Temferon in glioblastoma patients, including those with unmethylated MGMT; the trial is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temferon (temferon)

Snippet

Sponsor: Genenta Science | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING